5 Comments
Feb 12Liked by Devin LaSarre

Not sure if this has ever come up in a Q&A, but why does PMI exclude traditional oral in presentations and press releases? e.g. 2023Q4 slide 8 note (a): "[Oral nicotine category e]xcludes snuff, snuff leaf and U.S. chew." Is PMI possibly preparing to sell traditional brands such as General, Göteborgs Rapé, and Grov?

Expand full comment
Feb 12Liked by Devin LaSarre

I don’t smoke but sometimes I feel like trying out some of these new generation products, just so I know what my companies invest in. Alas here in the nanny state of Oz I need a prescription to purchase a vape, I kid you not. So I haven’t bothered. I might have to invest in a Japanese research trip :)

Expand full comment

Thank you for addressing the BAT - PMI global patent settlement!

Has PMI decided against divested its Russian operations? I might be confused, but I thought that was their goal after Russia’s invasion of Ukraine. However in their 2024 guidance they have dropped language about divestment.

One thing I find frustrating about PMI (and for that matter all the major nicotine companies): they “adjust away” so many losses. Their 2024 GAAP EPS is $5.02 vs $6.01 after adjustments. In comparison, SWMA had extremely clean financials with usually no adjustments.

Expand full comment